FDA clears Lilly’s Retevmo for RET-positive lung, thyroid cancersEli Lilly now has a second approved drug from its takeover of Loxo Oncology last year after getting Share XFDA clears Lilly’s Retevmo for RET-positive lung, thyroid cancershttps://pharmaphorum.com/news/fda-clears-lillys-retevmo-for-ret-positive-lung-thyroid-cancers/
